Enrico Cipro Vanni
Director/Board Member at ADVANCED ONCOTHERAPY PLC
Net worth: 3 M $ as of 2023-08-30
Enrico Cipro Vanni active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ADVANCED ONCOTHERAPY PLC | Director/Board Member | 2013-09-30 | - |
| Independent Dir/Board Member | 2013-09-30 | - | |
| Denzler & Partners | Director/Board Member | 2010-09-13 | - |
Banque Privée BCP (Suisse) SA
 Banque Privée BCP (Suisse) SA Regional BanksFinance Banque Privée BCP SA provides private banking services to individual and institutional clients. It offers advisory, discretionary management, and execution services. The firm also offers deposits and other cash management, equity and equity funds, bonds and bond funds, commodities, and foreign exchange. The company is headquartered in Geneva, Switzerland. | Director/Board Member | 2008-12-31 | - |
| Jan Autos Holding SA | Director/Board Member | - | - |
Lombard Odier & Cie (France) SA
 Lombard Odier & Cie (France) SA Financial ConglomeratesFinance Part of Compagnie Lombard Odier SCmA, Lombard Odier & Cie (France) SA operates as a French investment company. The company is based in Paris, France. | Director/Board Member | - | - |
Career history of Enrico Cipro Vanni
Former positions of Enrico Cipro Vanni
| Companies | Position | Start | End |
|---|---|---|---|
Eclosion2 SA
 Eclosion2 SA Financial ConglomeratesFinance Eclosion2 SA provides financial services. | Director/Board Member | 2011-08-24 | 2016-12-31 |
| ALCON INC. | Director/Board Member | 2010-09-12 | 2010-12-31 |
| Mckinsey & Co., Inc. (Switzerland) | Director/Board Member | 2006-12-31 | 2006-12-31 |
| ALLERGAN PLC | Director/Board Member | 2009-12-31 | - |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Training of Enrico Cipro Vanni
| École Polytechnique Fédérale de Lausanne | Undergraduate Degree |
| University of Lausanne | Doctorate Degree |
| INSEAD | Masters Business Admin |
Statistics
International
| Switzerland | 11 |
| France | 3 |
| United Kingdom | 2 |
Operational
| Director/Board Member | 11 |
| Independent Dir/Board Member | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 4 |
| Finance | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| ALCON INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| ADVANCED ONCOTHERAPY PLC | Health Technology |
| Private companies | 8 |
|---|---|
| Mckinsey & Co., Inc. (Switzerland) | |
Eclosion Foundation
 Eclosion Foundation Investment Trusts/Mutual FundsMiscellaneous Eclosion Foundation offers researchers managerial and scientific support for their projects, from finance to validation resources. The firm also provides premises, laboratories, and services adapted to the needs of their clients. It focuses on biotechnology and biomedical engineering sectors. The company was founded by Jesús Martin-Garcia and Benoit Dubois and is headquartered in Plan-les-Ouates, Switzerland. | Miscellaneous |
| Denzler & Partners | |
Eclosion2 SA
Eclosion2 SA Financial ConglomeratesFinance Eclosion2 SA provides financial services. | Finance |
Banque Privée BCP (Suisse) SA
Banque Privée BCP (Suisse) SA Regional BanksFinance Banque Privée BCP SA provides private banking services to individual and institutional clients. It offers advisory, discretionary management, and execution services. The firm also offers deposits and other cash management, equity and equity funds, bonds and bond funds, commodities, and foreign exchange. The company is headquartered in Geneva, Switzerland. | Finance |
| Jan Autos Holding SA | |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Lombard Odier & Cie (France) SA
Lombard Odier & Cie (France) SA Financial ConglomeratesFinance Part of Compagnie Lombard Odier SCmA, Lombard Odier & Cie (France) SA operates as a French investment company. The company is based in Paris, France. | Finance |
- Stock Market
- Insiders
- Enrico Cipro Vanni
- Experience
